Vasoactive Intestinal Peptide Receptor 1 (VIPR1) (C-Term) Peptid
Kurzübersicht für Vasoactive Intestinal Peptide Receptor 1 (VIPR1) (C-Term) Peptid (ABIN8115685)
Target
Spezies
Quelle
Applikation
-
-
Protein Region
- C-Term
-
Verwendungszweck
- VIPR1 Peptide - C-terminal region
-
Sequenz
- WRRWHLQGVL GWNPKYRHPS GGSNGATCST QVSMLTRVSP GARRSSSFQA
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Kommentare
-
This is a synthetic peptide designed for use in combination with anti- VIPR1 Antibody (ARP81909_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- VIPR1 (Vasoactive Intestinal Peptide Receptor 1 (VIPR1))
-
Hintergrund
-
Background Information: This gene encodes a receptor for vasoactive intestinal peptide, a small neuropeptide. Vasoactive intestinal peptide is involved in smooth muscle relaxation, exocrine and endocrine secretion, and water and ion flux in lung and intestinal epithelia. Its actions are effected through integral membrane receptors associated with a guanine nucleotide binding protein which activates adenylate cyclase. Several transcript variants encoding different isoforms have been found for this gene.
Alternative Symbols: II, HVR1, RDC1, V1RG, VIPR, VIRG, VAPC1, VPAC1, VPAC1R, VIP-R-1, VPCAP1R, PACAP-R2, PACAP-R-2
-
Molekulargewicht
- 54 kDa
-
Gen-ID
- 7433
-
NCBI Accession
- NP_001238811
-
UniProt
- P32241
Target
-